Le Lézard
Classified in: Health
Subject: PDT

Dr. David Mahjoubi Announces Move to a New Location for the Ketamine Healing Clinic of Los Angeles


LOS ANGELES, Sept. 16, 2019 /PRNewswire-PRWeb/ -- Ketamine Healing Clinic of Los Angeles, now located at 1762 Westwood Blvd Suite 320 Los Angeles CA 90024, provides effective doses of IV Ketamine for patients suffering from chronic pain and depression. Every infusion of Ketamine is specifically tailored to each patient, allowing Dr. Mahjoubi to individualize patient care. The new location offers a more patient-friendly atmosphere, with spacious, private rooms and home-like decor. Dr. David Mahjoubi is one of the only doctors in the country who utilizes ketamine nasal spray as a supplementary at-home treatment for depression and chronic pain. With the use of such advanced treatment and care, relocating offices will provide patients with an even greater sense of healing and attention.

The new location for Ketamine Healing Clinic of Los Angeles delivers the most advanced and comfortable IV Vitamin and Ketamine treatments to patients. Dr. Mahjoubi deeply understands that patients come to his clinic for healing from deeply rooted pain. Whether the pain is physical, mental, or emotional, Dr. Mahjoubi has created an atmosphere where patients can find relaxation and comfort during their treatments. The new office location is set up like a medical boutique that is equipped with quiet, private rooms for every patient. Genuine leather electronic recliners that rest in various positions are furnished with noise-canceling headphones with or without music streaming. Dr. Mahjoubi has pulled out all the stops to ensure that his patients find the comfort they desire during heir treatment. Patients will feel at ease the moment they step into the new location of Ketamine Healing Clinic.

"I am so proud to be able to offer Ketamine treatments for my patients who have been resistant to other treatments for depression and pain. Our new office facilities are the perfect combination of medical excellence and streamlined comfort," remarks Dr. David Mahjoubi of Ketamine Healing Clinic of Los Angeles.

More About Dr. David Mahjoubi of Ketamine Healing Clinic of Los Angeles:

David Mahjoubi, MD, is a Board-Certified Anesthesiologist and Diplomate of the American Board of Anesthesiology. He earned his Doctor of Medicine at The Chicago Medical School, and completed his residencies at UCLA Medical Center and USC/L.A. Country Hospital. Dr. Mahjoubi carries over a decade of experience with intravenous Ketamine dating back to 2007. He is the author of
multiple publications in the medical field and holds high honors from his educational years. Following his residency, Dr. Mahjoubi joined the Anesthesia Group at Northridge Hospital Medical Center and became the most active user of IV Ketamine for both conscious sedation and general anesthesia cases. After providing conscious sedation with Ketamine, he quickly noted the beneficial mental health effects of IV Ketamine in many patients post-procedurally. Ketamine Healing Clinic of Los Angeles was thus founded in 2014, and now provides a highly effective treatment for patients suffering from Depression, Anxiety, PTSD, and chronic pain including CRPS.
To learn more about IV or intranasal Ketamine treatment from Dr. David Mahjoubi, please contact his Los Angeles clinic at (424) 278-4241 or visit the following website at http://www.ketaminehealing.com.

 

SOURCE Ketamine Healing Clinic of Los Angeles


These press releases may also interest you

at 08:50
HLS Therapeutics Inc. ("HLS" or the "Company") , announces that it will release its Q1 fiscal 2024 financial results on Thursday, May 9, 2024. The Company will hold a conference call that same day at 8:30 a.m. ET to discuss its results. The call will...

at 08:50
Zentiva, a Pan-European pharmaceutical company, joined the inaugural launch of the EU's Critical Medicines Alliance, held on April 24-25 in Brussels. This significant event, organized by DG HERA and the Belgian Presidency, convened leaders from...

at 08:46
Orchid, a reproductive technology company offering the world's only commercially available whole genome embryo screening, today announced Dr. Amber Cooper, Dr. Roohi Jeelani, and Jerry Lanchbury, Ph.D as new members joining their Medical and...

at 08:45
Cannabix Technologies Inc. (the "Company or Cannabix") developer of alcohol and marijuana breathalyzer screening devices for law enforcement and the workplace reports that Friedel, LLC ("Friedel Clinic") a private monitoring agency, based in...

at 08:45
Wheel, the virtual care platform powering the future of care, today announced a strategic partnership with Owlet, Inc. ("Owlet") , the pioneer of smart infant monitoring. As part of this direct-to-consumer virtual offering, Wheel clinicians will...

at 08:43
The AKC Canine Health Foundation (CHF), a nonprofit organization dedicated to advancing the health of all dogs and their owners, announces that Purina has donated $111,910 in support of CHF-funded canine health research thanks to its Purina Parent...



News published on and distributed by: